We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.02B
AUM Growth
+$4.67M
Cap. Flow
+$2.09M
Cap. Flow %
0.21%
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6

Top Sells

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$566K
2
SYK icon
Stryker
SYK
+$501K
3
MSFT icon
Microsoft
MSFT
+$415K
4
ARRY
Array Biopharma Inc
ARRY
+$369K
5
GS icon
Goldman Sachs
GS
+$321K

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 17.23%
3 Financials 11.97%
4 Consumer Staples 10.84%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBE icon
176
State Street SPDR S&P Bank ETF
KBE
$1.64B
$194K 0.02%
10,250
FCX icon
177
Freeport-McMoran
FCX
$86.2B
$129K 0.01%
13,484
BKNG icon
178
Booking.com
BKNG
$156B
-3,100
Closed -$232K
GS icon
179
Goldman Sachs
GS
$289B
-1,568
Closed -$321K
IEX icon
180
IDEX
IEX
$17B
-1,212
Closed -$209K
EV
181
DELISTED
Eaton Vance Corp.
EV
-7,082
Closed -$305K
APC
182
DELISTED
Anadarko Petroleum
APC
-3,139
Closed -$221K
ARRY
183
DELISTED
Array Biopharma Inc
ARRY
-7,965
Closed -$369K

Similar funds

Grandfield & Dodd's Q3 2019 Portfolio in Review

As of Q3 2019, Grandfield & Dodd held 183 positions worth $1.02B, up 0.46% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Grandfield & Dodd opened 2 new positions and exited 6, leaving the 183-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2019 buy was iShares Russell 1000 Growth ETF: 5,832 shares worth $233K.
  • Grandfield & Dodd added most to Blackbaud in Q3 2019, an estimated $880K increase.
  • Grandfield & Dodd's biggest Q3 2019 reduction was Amdocs, cutting an estimated $566K.
  • Grandfield & Dodd fully exited Array Biopharma Inc in Q3 2019, selling an estimated $369K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.02B portfolio in Q3 2019.
  • Grandfield & Dodd opened 2 new positions and closed 6 in Q3 2019.
  • Grandfield & Dodd's portfolio value rose 0.46% quarter-over-quarter to $1.02B.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.